Search research articles
Contact Us
Filters
Showing results (71-80 of 92) with videos related to
Page
of 10
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 23, 2019
Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade
Imran G House, Peter Savas, Junyun Lai, et al.
Nature Immunology
|
May 20, 2020
Adoptive cellular therapy with T cells expressing the dendritic cell growth factor Flt3L drives epitope spreading and antitumor immunity
Junyun Lai, Sherly Mardiana, Imran G House, et al.
Immunology and Cell Biology
|
November 12, 2014
CD3bright signals on γδ T cells identify IL-17A-producing Vγ6Vδ1+ T cells
C Paget, M T Chow, N A Gherardin, et al.
Nature
|
February 28, 2020
Sex-specific adipose tissue imprinting of regulatory T cells
Ajithkumar Vasanthakumar, David Chisanga, Jonas Blume, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
December 3, 2025
Development of a high-affinity anti-ROR1 variable region for broad anti-cancer immunotherapy
Joshua K M Wong, Pui Yeng Lam, Elaina Coleborn, et al.
Nature
|
August 17, 2017
CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity
Marian L Burr, Christina E Sparbier, Yih-Chih Chan, et al.
Cancer Discovery
|
May 15, 2021
CDK4/6 Inhibition Promotes Antitumor Immunity through the Induction of T-cell Memory
Emily J Lelliott, Isabella Y Kong, Magnus Zethoven, et al.
Nature Medicine
|
June 27, 2018
Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis
Peter Savas, Balaji Virassamy, Chengzhong Ye, et al.
Immunity
|
November 4, 2025
Microbiota-derived butyrate promotes a FOXO1-induced stemness program and preserves CD8<sup>+</sup> T cell immunity against melanoma
Annabell Bachem, Michele Clarke, Geraldine Kong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 31, 2015
RAS/MAPK Activation Is Associated with Reduced Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer: Therapeutic Cooperation Between MEK and PD-1/PD-L1 Immune Checkpoint Inhibitors
Sherene Loi, Sathana Dushyanthen, Paul A Beavis, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 92) with videos related to
Sort By:
Page
of 10
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 23, 2019
Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade
Imran G House, Peter Savas, Junyun Lai, et al.
Nature Immunology
|
May 20, 2020
Adoptive cellular therapy with T cells expressing the dendritic cell growth factor Flt3L drives epitope spreading and antitumor immunity
Junyun Lai, Sherly Mardiana, Imran G House, et al.
Immunology and Cell Biology
|
November 12, 2014
CD3bright signals on γδ T cells identify IL-17A-producing Vγ6Vδ1+ T cells
C Paget, M T Chow, N A Gherardin, et al.
Nature
|
February 28, 2020
Sex-specific adipose tissue imprinting of regulatory T cells
Ajithkumar Vasanthakumar, David Chisanga, Jonas Blume, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
December 3, 2025
Development of a high-affinity anti-ROR1 variable region for broad anti-cancer immunotherapy
Joshua K M Wong, Pui Yeng Lam, Elaina Coleborn, et al.
Nature
|
August 17, 2017
CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity
Marian L Burr, Christina E Sparbier, Yih-Chih Chan, et al.
Cancer Discovery
|
May 15, 2021
CDK4/6 Inhibition Promotes Antitumor Immunity through the Induction of T-cell Memory
Emily J Lelliott, Isabella Y Kong, Magnus Zethoven, et al.
Nature Medicine
|
June 27, 2018
Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis
Peter Savas, Balaji Virassamy, Chengzhong Ye, et al.
Immunity
|
November 4, 2025
Microbiota-derived butyrate promotes a FOXO1-induced stemness program and preserves CD8<sup>+</sup> T cell immunity against melanoma
Annabell Bachem, Michele Clarke, Geraldine Kong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 31, 2015
RAS/MAPK Activation Is Associated with Reduced Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer: Therapeutic Cooperation Between MEK and PD-1/PD-L1 Immune Checkpoint Inhibitors
Sherene Loi, Sathana Dushyanthen, Paul A Beavis, et al.
Page
of 10